Practice Management News

For patients with nonalcoholic fatty liver disease, no difference was found between moderate and vigorous exercise in reducing liver fat, according to recent findings published in JAMA Internal Medicine.

The NIH announced $55 million in awards for fiscal year 2016 to launch a key component of President Barack Obama’s Precision Medicine Initiative.

SuperSonic Imagine announced completion of enrollment for a large prospective multicenter liver study in China. The company seeks to evaluate the performance of its real-time ShearWave Elastography for the non-invasive assessment of liver fibrosis in patients with chronic hepatitis B infection.

Varying levels of physical activity decreased the risk for developing new fatty liver and assisted in resolution of existing fatty liver within 5 years of follow up.

Physicians are reporting difficulty adapting to a changing health care system in the United States, according to a survey.

HHS reported that 93% of new Medicaid enrollees are satisfied with their health care plans, and 92% are satisfied with their doctors. In addition, 78% of new enrollees state that they would be unable to access regular care if not for the Affordable Care Act.

Healio.com/Hepatology compiled a list of the top 10 news reports on hepatology posted from June 1 to June 30.

From international law firm Arnold & Porter LLP comes a timely column that provides views on current regulatory and legislative topics that weigh on the minds of today’s physicians and health care executives.

The AGA met with CMS and Congress this week to express its support for specialty alternative payment models under the Medicare Access and Chip Reauthorization Act of 2015, or MACRA, which proposes a new Medicare reimbursement system that is expected to become effective in 2017 and begin affecting payments in 2019, according to a press release.

Clinical Care Options announced a new partnership with AASLD which will provide a new education program for providers on how to treat patients with hepatitis C virus infection with new therapies, according to a news release.